Srinagar: There is a silver lining to every cloud. While COVID-19 infection rates are steadily rising in Jammu and Kashmir, the number of recovered patients is also increasing.
According to official data, the total number of recovered patients in J&K is 247. Of who, 196 are from Kashmir and 51 are from Jammu.
In Kashmir, Srinagar tops the list in the recovered patients. Sixty-nine patients have recovered in Srinagar followed by Bandipora 35, Baramulla 26, Kupwara 19, Shopian 17, Ganderbal 13, Budgam 11, Kulgam 3 and Pulwama 3.
Twenty-six patients have recovered in Jammu district followed by Udhampur 17, Samba 4, Rajouri 3, and Kishtwar 1. The data, further, indicates that the pattern of COVID-19 in J&K is showing a linear growth.
Figures reveal that 71,837 persons are under observation and 8109 persons are under home quarantine. The total number of patients kept in hospital isolation is 384 while the patients kept under hospital quarantine are 185.
Figures show that the active positive cases in J&K are 384. Eight deaths have taken place in J&K so far.
On Thursday, the Ministry of Health and Family Welfare said India’s recovery rate of Covid-19 positive patients has steadily climbed to 25.19%, up from 13% fourteen days ago.
As per the data, India has recorded 10,007 recovered/ discharged patients at present.
HOD Chest Diseases Hospital, Srinagar, which is designated as COVID-19 Hospital, Dr Naveed Nazir Shah said the majority of patients who tested positive for COVID-19 are asymptomatic.
“Around 80-90 percent of positive patients have shown mild symptoms,” he said.
Dr Naveed noted that Kashmir has not entered into the community transmission stage yet. “All the patients reported to us had either travel or contact history,” he said.
The treatment administered to patients, as per the doctors, is being given as per the Indian Council of Medical Research guidelines.
Medical Superintendent SKIMS Dr Farooq Jan said the degree of illness reported in COVID-19 positive patients is “mild”. “The treatment given to them includes Hydroxychloroquine, symptomatic treatment, and anti-viral drugs,” he said.
